Eye Disease and Blindness

Active Projects: 95

Project Investigator
 		All Topics Start date End date
Macular Edema Treatment Trials Associated with MUST (META-MUST) Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis (ADVISE) Trial Nisha Acharya, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Clinical Research Fellowship for Nisha Acharya Nisha Acharya, MD Eye Disease and Blindness
Effect of Ranibizumab on Refractory Macular Edema in Uveitis Phase I/II Nisha Acharya, MD Eye Disease and Blindness
Multicenter Study in treating Macular Edema Nisha Acharya, MD Eye Disease and Blindness
Predicting and Improving Outcomes in Bacterial and Fungal Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Iontophoresis Delivery of Dexamethason Phosphate for Non-Infectious, No-Necrotizing Anterior Scieritis, Phase I Dose-Varying Study Nisha Acharya, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Multicenter Uveitis Steroid Treatment (MUST) Trial Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development
Predicting and Improving Critical Outcomes for Bacterial Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Macular Edema Treatment Trials Associated with MUST (META-MUST) Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development
F.I. Proctor Foundation Uveitis Fellowship training program Nisha Acharya, MD Eye Disease and Blindness, Training and Capacity Building
Mycotic Ulcer Treatment Trial (MUTT) Nisha Acharya, MD Infectious Disease, Eye Disease and Blindness
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial Nisha Acharya, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Trial (ADJUST) Nisha Acharya, MD Eye Disease and Blindness, Immunology
Phase 1 Iontophoretic Delivery of Dexamethasone for Tx of Anterior Scleritis Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis Nisha Acharya, MD Eye Disease and Blindness
Fellowship - Award - 2016-2017 Pathogenesis and Treatment of Ebola-Associated Uveitis Rationale Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial Nisha Acharya, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma Eye Disease and Blindness
Immunologic determinants of age-related macular degeneration Peter Hunt, MD Eye Disease and Blindness, Immunology, Aging
CDA - Improving the Diagnosis and Treatment of Acanthamoeba Keratitis Jeremy Keenan, MD, MPH Eye Disease and Blindness
Planning Grant for Parasitic Ulcer Treatment Trial Jeremy Keenan, MD, MPH Eye Disease and Blindness
Village-Integrated Eye Worker trial II (VIEW II) Jeremy Keenan, MD, MPH Eye Disease and Blindness, Training International Scholars and Clinicians, Patient and Peer Education
Optimal Trachoma Control after Mass Antibiotic Distributions Jeremy Keenan, MD, MPH Eye Disease and Blindness
Sanitation, Water, and Instruction in Face-washing for Trachoma (SWIFT) Jeremy Keenan, MD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Village Integrated Eye Worker Trial II - Keenan/Carl Zeiss Meditec Jeremy Keenan, MD, MPH Eye Disease and Blindness
Studies of Ocular Complications of AIDS (SOCA) HIV/AIDS, Eye Disease and Blindness
Predicting Resistance: Validating Mathematical Models Thomas Lietman, MD Eye Disease and Blindness, Epidemiology and Surveillance
Village Integrated Eye Workers Trial Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness, Risk Reduction and Prevention
Eliminating Trachoma with Repeat Mass Drug Treatment Thomas Lietman, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
What is the Appropriate Frequency and Duration of Mass Azithromycin Thomas Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Strategies for the Control and Elimination of Blinding Trachoma Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Trachoma control in Africa through mass antibiotic administration, and corneal ulcer prevention and treatment in South Asia Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness
Elimination of Infectious Trachoma from Ethiopia Using Repeated Mass Antibiotic Distributions Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Digital Detection of Infectious Eye Epidemics Thomas Lietman, MD Eye Disease and Blindness
P-S RPB - Assessing Corneal Ulcer Prevention with a Community-Randomized Trial Thomas Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Research to Programs for Trachoma Elimination Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Mortality Reduction After Oral Azithromycin Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Epidemiology and Surveillance
Forecasting Trachoma Control Thomas Lietman, MD Eye Disease and Blindness, Epidemiology and Surveillance, Global Strategic Information
Quantitative analysis and modelling on targets and strategies for alleviating the burden of priority neglected tropical diseases Thomas Lietman, MD Eye Disease and Blindness
Mycotic Ulcer Treatment Trial Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Village Integrated Eye Workers Trial Thomas Lietman, MD Eye Disease and Blindness
Leveraging Core Groups -- A New Way to Protect Against Infectious Trachoma Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance
The Steroids for Corneal Ulcers Trial Thomas Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment
Planning Grant for a large scale azithromycin trial for prevention of under-5 mortality in Niger Thomas Lietman, MD Malaria, Eye Disease and Blindness, Pediatrics
TANA II Thomas Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Steroids and Cross-linking for Ulcer Treatment (SCUT II) Thomas Lietman, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Infectious and inflammatory eye disease epidemic detection and seasonality Thomas Lietman, MD Eye Disease and Blindness
Tools for the Endgame: Accelerating the development and introduction of Dx to Support the London Declaration 2020 goals for Neglected Tropical Diseases (NTDs) Thomas Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Epidemiology of infectious disease Travis Porco, PhD, MPH Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance
Modeling Contact Investigation and Rapid Response Travis Porco, PhD, MPH Eye Disease and Blindness
Detection of C. trachomatis on eye swabs Julius Schachter, PhD Eye Disease and Blindness, Drug and Diagnostics Development
Epidemiology and clinical manifestations of chlamydial infections Julius Schachter, PhD Eye Disease and Blindness
A point of care assay for chlamydia to assure prompt treatment in at risk minorities Julius Schachter, PhD Infectious Disease, Eye Disease and Blindness, Drug and Diagnostics Development
Processing Uganda Swabs for Trachoma Alternative Indicators Study Julius Schachter, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Sjögren’s International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen) Caroline Shiboski, DDS, MPH, PhD Eye Disease and Blindness, Oral Health
Sjögren International Collaborative Clinical Alliance (SICCA) Biorepository Caroline Shiboski, DDS, MPH, PhD Eye Disease and Blindness, Oral Health
International Clinical Research Fellowship Christopher Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
Nanoporous Films for Ocular Drug Delivery Tejal Desai, PhD Eye Disease and Blindness, Drug and Diagnostics Development
NDC for the Optical Control of Biological Function Jacque Duncan, MD Eye Disease and Blindness
Studies of the Ocular Complications of AIDS (SOCA) Jacque Duncan, MD HIV/AIDS, Eye Disease and Blindness
Advanced Technology to Study Visual Function on a Cellular Scale Jacque Duncan, MD Eye Disease and Blindness
New Enrollment Post-Approval Study of the Argus II Retinal Prosthesis System Jacque Duncan, MD Eye Disease and Blindness
High Resolution Retinal Imaging in Patients with Age-Related Macular Degeneration and other Retinal Degenerative Diseases Jacque Duncan, MD Eye Disease and Blindness
Noninvasive Assessment of Photoreceptor Structure and Function in Retinitis Pigmentosa with Adaptive Optics Scanning Laser Ophthalmoscopy Jacque Duncan, MD Eye Disease and Blindness
Mactel Natural History Observation and Registry Study Jacque Duncan, MD Eye Disease and Blindness
Molecular Basis of Hereditary Retinal Degenerations Jacque Duncan, MD Eye Disease and Blindness
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Jacque Duncan, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
The relationship between structure and function in inherited retinal disease Jacque Duncan, MD Eye Disease and Blindness
Assessment of cone structure and function with high resolution in eyes with retinal degeneration Jacque Duncan, MD Eye Disease and Blindness
Signal Processing in the Retina Eye Disease and Blindness
Eliminating Trachoma with Repeat Mass Drug Treatment Eye Disease and Blindness
Regulation of Herpes Simplex Type 1 Infection in Corneal Neurons Eye Disease and Blindness
Characterization of TRPM1 isoforms and binding partners in ON bipolar cells Eye Disease and Blindness
Predictors of Response to Treatment in Fungal Keratitis Jennifer Rose-Nussbaumer, MD Eye Disease and Blindness
UCSF RPB Unrestricted Grant Application Stephen Mcleod, MD Infectious Disease, Eye Disease and Blindness
Diagnosis and treatment of infectious keratitis Stephen Mcleod, MD Infectious Disease, Eye Disease and Blindness
RPB Unrestricted Grant Stephen Mcleod, MD Eye Disease and Blindness
The Efficacy of Topically Applied Nepafenac in Prolonging Mydriasis in a Model of Phacoemusification Stephen Mcleod, MD Eye Disease and Blindness
Center for the Child with Visual Disabilities Stephen Mcleod, MD Eye Disease and Blindness, Pediatrics
UCSF RPB Unrestricted Grant Application Stephen Mcleod, MD Infectious Disease, Eye Disease and Blindness
2007 Horizon Grants Program - Retina Stephen Mcleod, MD Eye Disease and Blindness, Residencies, Fellowships, and Postdoctoral Training
2008 Horizon Grants Program - F.I. Proctor Fellowship Stephen Mcleod, MD Eye Disease and Blindness, Residencies, Fellowships, and Postdoctoral Training
Impact of Antibiotics on the Ocular Surface Microbiome and Ophthalmic Infectious Diseases Thuy Doan, MD, MPH Eye Disease and Blindness
Ocular Surface Microbiome, Virome, and Pathogens in Ophthalmic Disease and Health Thuy Doan, MD, MPH Eye Disease and Blindness
Improving the quality of refractive eye care services provided in outreach camps and primary care centers in India: a mixed methods study Talita Rosa, MD Eye Disease and Blindness
Closing the Primary Eye Care Gap in Southern India Jamen Garcia, MS Eye Disease and Blindness
Kebele Elimination of Trachoma for Ocular Health Catherine Oldenburg, ScD, MPH Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Targeted Azithromycin Strategies for Trachoma Elimination in Ethiopia Catherine Oldenburg, ScD, MPH Eye Disease and Blindness, Epidemiology and Surveillance
Chlamydial sexually transmitted diseases and trachoma Deborah Dean, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness, Drug and Diagnostics Development
Trachoma in Southwestern Nepal Deborah Dean, MD, MPH Infectious Disease, Eye Disease and Blindness
Effectiveness of Tele-ophthalmology on Eye Care in Rural Southern India Rachel Chung, MS Eye Disease and Blindness, Training International Scholars and Clinicians
Seroepidemiologic methods to identify hotspots of trachoma and predict future infection Benjamin F. Arnold, PhD Eye Disease and Blindness, Epidemiology and Surveillance

Active Investigators: 1